ישראל -
עברית -
Ministry of Health
ריזלט אר.פי.די 10 מג טבליות מסיסות
organon pharma israel ltd., israel - rizatriptan as benzoate - טבליות מתמוססות בפה - rizatriptan as benzoate 10 mg - rizatriptan - rizatriptan - rizalt is indicated for the acute treatment of migraine attacks with or without aura in adults.
ישראל -
עברית -
Ministry of Health
אלפא די 3 0.5 מק"ג
teva pharmaceutical indust.ltd - alfacalcidol 0.5 mcg - capsules - alfacalcidol - renal bone disease . hypoparathyroidisim. rickets and osteomalacia. osteoporosis. primary and tertiary hyperparathyroidism. neonatal hypocalcemia.
ישראל -
עברית -
Ministry of Health
אלפא די 3 0.25 מקג
truemed ltd, israel - alfacalcidol - קפסולות ג'לטין רכות - alfacalcidol 0.25 mcg - alfacalcidol - alfacalcidol - renal bone disease (renal osteodystrophy), hypoparathyroidism, hyperparathyroidism (with bone disease) - primary and tertiary. neonatal hypocalcemia, rickets and osteomalacia, osteoporosis.
ישראל -
עברית -
Ministry of Health
טבאלפא די 3 0.25 מקג
teva pharmaceutical industries ltd, israel - alfacalcidol - קפסולות ג'לטין רכות - alfacalcidol 0.25 mcg - alfacalcidol - alfacalcidol - renal bone disease (renal osteodystrophy), hypoparathyroidism, hyperparathyroidism (with bone disease) - primary and tertiary. neonatal hypocalcemia, rickets and osteomalacia, osteoporosis.
ישראל -
עברית -
Ministry of Health
אלפא די 3 1.0 מקג
truemed ltd, israel - alfacalcidol - קפסולות ג'לטין רכות - alfacalcidol 1 mcg - alfacalcidol - alfacalcidol - renal bone disease (renal osteodystrophy), hypoparathyroidism, hyperparathyroidism (with bone disease) - primary and tertiary. neonatal hypocalcemia, rickets and osteomalacia, osteoporosis.
ישראל -
עברית -
Ministry of Health
אלפא די 3 1.0 מקג
teva pharmaceutical industries ltd, israel - alfacalcidol - קפסולות ג'לטין רכות - alfacalcidol 1 mcg - alfacalcidol - alfacalcidol - renal bone disease (renal osteodystrophy), hypoparathyroidism, hyperparathyroidism (with bone disease) - primary and tertiary. neonatal hypocalcemia, rickets and osteomalacia, osteoporosis.
ישראל -
עברית -
Ministry of Health
קם-רהו די i.m
kamada ltd, israel - anti-d immunoglobulins - תמיסה להזרקה - anti-d immunoglobulins 150 mcg/ml - anti-d (rh) immunoglobulin - anti-d (rh) immunoglobulin - pregnancy/other obstetric conditions, suppression of rh immunization in non-sensitized rh0 (d) negative women delivering an rh0 positive baby or when the baby's rh type is unknown. suppression of rh immunization after spontaneous or induced abortions threatened abortion associated with maternal bleeding amniocentesis chorionic villus sampling ruptured tubal pregnancy and significant abdominal trauma. kam rh0 -d im should be given within 72 hours of the event. it may be given even after up to one month although efficacy may be somewhat reduced.transfusion: suppression of rh isoimmunization in rh0 (d) antigen-negative patients transfused with rh0 (d) antigen-positive rbcs of blood components containing rh0 (d) antigen-positive rbcs . initate treatment within 72 hours of exposure.